Sheridan Capital Partners has invested in Carolina Components Group (CCG), a provider of bioprocessing assemblies and components used in biopharmaceutical manufacturing. Founded in 2020 and headquartered in Durham, North Carolina, CCG serves the growing demand for biomanufacturing supplies. Sheridan, a Chicago-based healthcare-focused firm established in 2012, pursues buyouts and growth equity investments in the lower middle market.

The firm targets providers, outsourced services, products, manufacturing, and software. While financial terms remain undisclosed, the partnership signals continued investor confidence in the specialized bioprocessing sector. This investment adds to Sheridan's portfolio of healthcare infrastructure companies.